Ke Xu

Employment

• Memorial Sloan Kettering Cancer Center Lab Technician
  2011 - 2015

Education

• Boston University Medical Campus MD/PhD
  2015 - Present
• Hamilton College BA
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (54)

• Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  Cancer Discovery 2025 DOI: 10.1158/2159-8290.CD-24-1055
  +Save
• Data from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.c.8126008
  +Save
• Supplementary Table S7 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516535
  +Save
• Supplementary Table S6 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516538
  +Save
• Supplementary Table S5 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516541
  +Save
• Supplementary Table S4 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516544
  +Save
• Supplementary Table S3 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516547
  +Save
• Supplementary Table S2 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516550
  +Save
• Supplementary Table S1 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516556
  +Save
• Supplementary Figure S7 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
  2025 DOI: 10.1158/2159-8290.30516559
  +Save